SUREMAB
Live / Registered — Registered (as of 19 Nov 2024)
What this means for you
Registered since 19 Nov 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98332384
- Registration number
- 7570798
- Mark type
- Stylized text
- Filed
- 27 Dec 2023
- Published for opposition
- 03 Sept 2024
- Registered
- 19 Nov 2024
- Attorney of record
- F. Michael Sajovec
Goods and services
- Class 042 — Scientific and technological services: Biotechnology research and development services for others, namely, mammalian cell line development, monoclonal antibody development, genome sequencing, genome mapping, genome and nucleic acid analysis, genome amplification, genome scanning, and high performance computing services for genome sequencing
Owner
- KBI Biopharma, Inc., Durham, NC, US
- KBI Biopharma, Inc., Durham, NC, US
- KBI Biopharma, Inc., Durham, NC, US
Prosecution history
- 19 Nov 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 19 Nov 2024 — REGISTERED-PRINCIPAL REGISTER
- 03 Sept 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Sept 2024 — PUBLISHED FOR OPPOSITION
- 14 Aug 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 Jul 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 26 Jul 2024 — ASSIGNED TO EXAMINER
- 10 Apr 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 27 Dec 2023 — NEW APPLICATION ENTERED